INTERLEUKIN-1 UP-REGULATES TRANSCRIPTION OF ITS OWN RECEPTOR IN A HUMAN FIBROBLAST CELL-LINE TIG-1 - ROLE OF ENDOGENOUS PGE2 AND CAMP

被引:52
作者
TAKII, T
AKAHOSHI, T
KATO, K
HAYASHI, H
MARUNOUCHI, T
ONOZAKI, K
机构
[1] NAGOYA CITY UNIV, FAC PHARMACEUT SCI, DEPT HYG CHEM, MIZUHO KU, NAGOYA, AICHI 467, JAPAN
[2] FUJITA GAKUEN HLTH UNIV, INST COMPREHENS MED SCI, DIV CELL BIOL, TOYOAKE, AICHI, JAPAN
[3] KITASATO UNIV, DEPT INTERNAL MED, SAGAMIHARA, KANAGAWA 228, JAPAN
关键词
D O I
10.1002/eji.1830220517
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The regulation of interleukin-1 receptor (IL-1R) mRNA expression by IL-1 in a human lung fibroblast cell line (TIG-1) was investigated. After 2 h of stimulation with human recombinant IL-1-alpha or IL-1-beta, the levels of T cell/fibroblast-type IL-1R mRNA increased, and the elevation was sustained for at least 72 h. IL-1 also stimulated synthesis of prostaglandin E2 (PGE2) and secondary cAMP accumulation. Exogenously added PGE2 increased the levels of both IL-1R mRNA and intracellular cAMP. Forskolin, cholera toxin and 8-Bromo adenosine (8-Br-cAMP) all increased IL-1R mRNA levels. Indomethacin blocked IL-1 stimulation of IL-1R mRNA expression, PGE2 production and cAMP. I-125-labeled IL-1-alpha-binding studies showed that this cell line expresses 2.6 x 10(4) IL-1R per cell with a k(d) of 5.1 x 10(-10) M. After treatment of the cells with IL-1, the level of IL-1R increased over that of control cells. PGE2 also increased IL-1R without alteration in its affinity. Cross-linking experiments indicate that this cell line expresses the 80-kDa receptor molecule before and after treatment with PGE2; the molecular mass corresponds to the T cell/fibroblast type I IL-1R. These results indicate that IL-1 does not directly stimulate expression of IL-1R mRNA or cell surface IL-1R, but only indirectly by stimulation of endogenous PGE2.
引用
收藏
页码:1221 / 1227
页数:7
相关论文
共 36 条
[11]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[12]  
DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]
[13]   DETECTION AND CHARACTERIZATION OF HIGH-AFFINITY PLASMA-MEMBRANE RECEPTORS FOR HUMAN INTERLEUKIN-1 [J].
DOWER, SK ;
KRONHEIM, SR ;
MARCH, CJ ;
CONLON, PJ ;
HOPP, TP ;
GILLIS, S ;
URDAL, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (02) :501-515
[14]   THE INTERLEUKIN-1 RECEPTOR [J].
DOWER, SK ;
URDAL, DL .
IMMUNOLOGY TODAY, 1987, 8 (02) :46-51
[15]   TRANSFORMING GROWTH-FACTOR-BETA IS A POTENT INHIBITOR OF INTERLEUKIN-1 (IL-1) RECEPTOR EXPRESSION - PROPOSED MECHANISM OF INHIBITION OF IL-1 ACTION [J].
DUBOIS, CM ;
RUSCETTI, FW ;
PALASZYNSKI, EW ;
FALK, LA ;
OPPENHEIM, JJ ;
KELLER, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) :737-744
[16]  
DUBOIS CM, 1990, EXP HEMATOL, V18, P255
[17]   INTERLEUKIN-1 AND LIPOPOLYSACCHARIDE INDUCE AN INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR INVIVO AND IN CULTURED ENDOTHELIAL-CELLS [J].
EMEIS, JJ ;
KOOISTRA, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05) :1260-1266
[18]   G-PROTEINS AND DUAL CONTROL OF ADENYLATE-CYCLASE [J].
GILMAN, AG .
CELL, 1984, 36 (03) :577-579
[19]  
LACEY DL, 1990, J IMMUNOL, V145, P4145
[20]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+